Mandeep Kumar Arora
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Mangiferin and Mango Extracts 2
- Co-authors
- Umesh Kumar Singh (2 shared papers)Pitchai Balakumar (4 shared papers)Ashok Jangra (11 shared papers)Krishna N. Reddy (1 shared paper)Mohd Imran (7 shared papers)Madhu B. Anand‐Srivastava (1 shared paper)Syed Mohammed Basheeruddin Asdaq (5 shared papers)Manjeet Singh (1 shared paper)
- Journals
- Saudi Journal of Biological Sciences (2 papers)Molecules (2 papers)Biomedicines (2 papers)Pharmacological Research (2 papers)Current Drug Targets (2 papers)
- Partner nations
- IndiaSaudi ArabiaUnited States
In The Last Decade
Mandeep Kumar Arora
39 papers receiving 922 citations
Peers
Comparison fields: 5 of 103
- Nephrology 138
- Clinical Biochemistry 79
- Endocrinology, Diabetes and Metabolism 158
- Complementary and alternative medicine 71
- Toxicology 23
Countries citing papers authored by Mandeep Kumar Arora
This map shows the geographic impact of Mandeep Kumar Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandeep Kumar Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandeep Kumar Arora more than expected).
Fields of papers citing papers by Mandeep Kumar Arora
This network shows the impact of papers produced by Mandeep Kumar Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandeep Kumar Arora. The network helps show where Mandeep Kumar Arora may publish in the future.
Co-authors
The 25 scholars most cited alongside Mandeep Kumar Arora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 200 | |
| 2 | 2021 | 141 | |
| 3 | 2014 | 69 | |
| 4 | 2009 | 63 | |
| 5 | 2009 | 60 | |
| 6 | 2010 | 53 | |
| 7 | 2023 | 42 | |
| 8 | 2009 | 42 | |
| 9 | 2023 | 33 | |
| 10 | 2018 | 30 | |
| 11 | 2020 | 30 | |
| 12 | 2023 | 25 | |
| 13 | 2022 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2020 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2023 | 14 | |
| 18 | 2022 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2007 | 8 |
About Mandeep Kumar Arora
Mandeep Kumar Arora is a scholar working on Molecular Biology, Complementary and alternative medicine, Epidemiology, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 44 papers that have together received 951 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Mangiferin and Mango Extracts (2 papers). The work is most often cited by research in Nephrology (138 citations), Clinical Biochemistry (79 citations), Endocrinology, Diabetes and Metabolism (158 citations), Complementary and alternative medicine (71 citations) and Toxicology (23 citations). Mandeep Kumar Arora has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Umesh Kumar Singh, Pitchai Balakumar, Ashok Jangra, Krishna N. Reddy, Mohd Imran, Madhu B. Anand‐Srivastava, Syed Mohammed Basheeruddin Asdaq, Manjeet Singh, Ritu Tomar and Mohammed Kanan Alshammari. Their work appears in journals such as Saudi Journal of Biological Sciences, Molecules, Biomedicines, Pharmacological Research and Current Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.